Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 28,643 | 28,618 | 26,729 | 33,490 | 29,635 |
| Cost of Goods | 11,430 | 11,965 | 10,646 | 12,769 | 11,421 |
| Gross Profit | 17,213 | 16,653 | 16,083 | 20,721 | 18,214 |
| Operating Expenses | 25,446 | 32,277 | 30,730 | 31,323 | 31,682 |
| Operating Income | -7,803 | -14,659 | -14,001 | -9,833 | -13,047 |
| Interest Expense | 1,451 | 1,451 | 1,453 | 1,450 | 1,453 |
| Other Income | -377 | 608 | -1,120 | -549 | -6 |
| Pre-tax Income | -9,631 | -15,502 | -16,574 | -11,832 | -14,506 |
| Income Tax | -362 | -266 | -643 | -888 | -716 |
| Net Income Continuous | -9,269 | -15,236 | -15,931 | -10,944 | -13,790 |
| Net Income | $-9,269 | $-15,236 | $-15,931 | $-10,944 | $-13,790 |
| EPS Basic Total Ops | -0.32 | -0.53 | -0.56 | -0.39 | -0.49 |
| EPS Basic Continuous Ops | -0.32 | -0.53 | -0.56 | -0.39 | -0.49 |
| EPS Diluted Total Ops | -0.32 | -0.53 | -0.56 | -0.39 | -0.49 |
| EPS Diluted Continuous Ops | -0.32 | -0.53 | -0.56 | -0.39 | -0.49 |
| EBITDA(a) | $-3,752 | $-10,418 | $-9,863 | $-5,894 | $-9,167 |